![](/img/cover-not-exists.png)
ABBV-105, a selective and irreversible inhibitor of Bruton’s Tyrosine Kinase (BTK), is efficacious in multiple preclinical models of inflammation
Goess, Christian, Harris, Christopher M., Murdock, Sara, McCarthy, Richard W., Sampson, Erik, Twomey, Rachel, Mathieu, Suzanne, Mario, Regina, Perham, Matthew, Goedken, Eric R., Long, Andrew J.Language:
english
Journal:
Modern Rheumatology
DOI:
10.1080/14397595.2018.1484269
Date:
June, 2018
File:
PDF, 1.49 MB
english, 2018